Pharmacyclics, Inc. (PCYC) Posts Q3 non-GAAP Loss of 18c/Sh
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q3 non-GAAP loss of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $37 thousand versus the consensus estimate of $2.41 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
